Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Shandong Luye Pharmaceutical
Shandong Luye Pharmaceutical
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Rykindo
Risperidone
2023-01-13
2025-2033
Dementia
,
Tourette syndrome
,
Schizophrenia
,
Bipolar disorder
,
Autistic disorder
,
Schizophrenia spectrum and other psychotic disorders
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Toludesvenlafaxine
depression
,
major depressive disorder
,
depressive disorder
Glycididazole
chemoradiotherapy
,
esophageal neoplasms
,
carcinoma
,
squamous cell carcinoma
Taxane
unknown primary neoplasms
,
squamous cell carcinoma of head and neck
,
renal cell carcinoma
,
liver neoplasms
,
biliary tract neoplasms
,
nasopharyngeal carcinoma
,
nasopharyngeal neoplasms
,
sex cord-gonadal stromal tumors
,
neuroendocrine carcinoma
,
triple negative breast neoplasms
,
neoplasms
,
ovarian neoplasms
,
stomach neoplasms
,
esophageal neoplasms
,
inflammatory breast neoplasms
,
ductal carcinoma breast
,
adenocarcinoma
,
neoplasm metastasis
,
castration-resistant prostatic neoplasms
,
neoplasms by site
,
lung neoplasms
,
mucinous adenocarcinoma
,
skin diseases
,
breast diseases
,
fallopian tube neoplasms
,
uterine cervical neoplasms
,
carcinoma
,
head and neck neoplasms
,
small cell lung carcinoma
,
peritoneal neoplasms
,
prostatic neoplasms
,
urinary bladder neoplasms
,
respiratory tract diseases
,
germ cell and embryonal neoplasms
,
lung diseases
,
respiratory tract neoplasms
,
bronchogenic carcinoma
,
thoracic neoplasms
,
bronchial diseases
,
neoplasms by histologic type
,
nerve tissue neoplasms
,
patient preference
,
ovarian epithelial carcinoma
,
lobular carcinoma
,
endometrial neoplasms
,
breast neoplasms
,
non-small-cell lung carcinoma
,
colonic neoplasms
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use